Delwedd Flaen

The AMPK-mTOR Pathway Is Inhibited by Chaihu Shugan Powder, Which Relieves Nonalcoholic Steatohepatitis by Suppressing Autophagic Ferroptosis

Nonalcoholic steatohepatitis (NASH) is the advanced stage of nonalcoholic fatty liver disease (NAFLD), which is distinguished by the accumulation of fat in the liver, damage to liver cells, and inflammation. Chaihu Shugan powder (CSP), a renowned traditional Chinese medicine (TCM) blend extensively...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Zheng Liang (Awdur), Dajin Pi (Awdur), Jianwei Zhen (Awdur), Haizhen Yan (Awdur), Chuiyang Zheng (Awdur), July Liang Chen (Awdur), Wen Fan (Awdur), Qingliang Song (Awdur), Jinyue Pan (Awdur), Dongdong Liu (Awdur), Maoxing Pan (Awdur), Qinhe Yang (Awdur), Yupei Zhang (Awdur)
Fformat:	Llyfr
Cyhoeddwyd:	Hindawi Limited, 2024-01-01T00:00:00Z.
Pynciau:	article
Mynediad Ar-lein:	Connect to this object online.
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Tanshinone IIA Inhibits the Endoplasmic Reticulum Stress-Induced Unfolded Protein Response by Activating the PPARα/FGF21 Axis to Ameliorate Nonalcoholic Steatohepatitis
gan: Dajin Pi, et al.
Cyhoeddwyd: (2024)

Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating sphingolipid and glycerinphospholipid metabolism
gan: Wei Li, et al.
Cyhoeddwyd: (2022)

Chaihu Shugan prevents cholesterol gallstone formation by ameliorating the microbiota dysbiosis and metabolic disturbance in mice
gan: Wei Wang, et al.
Cyhoeddwyd: (2024)

SIRT1/FOXO1 Axis-Mediated Hippocampal Angiogenesis is Involved in the Antidepressant Effect of Chaihu Shugan San
gan: Zhang S, et al.
Cyhoeddwyd: (2022)

Potential antidepressant effects of Traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients
gan: Ziyi Guo, et al.
Cyhoeddwyd: (2024)

Chaihu Shugan San promotes gastric motility in rats with functional dyspepsia by regulating Drp-1-mediated ICC mitophagy
gan: Li Li, et al.
Cyhoeddwyd: (2023)

Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8
gan: Zhiyue Li, et al.
Cyhoeddwyd: (2023)

Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
gan: Zhang S, et al.
Cyhoeddwyd: (2021)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
gan: Sisi Lei, et al.
Cyhoeddwyd: (2022)

Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis
gan: Qian Yu, et al.
Cyhoeddwyd: (2023)

Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress
gan: Xiaofei Zhu, et al.
Cyhoeddwyd: (2022)

Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway
gan: Sisi Lei, et al.
Cyhoeddwyd: (2024)

Chaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiota
gan: Sang-Kap Han, et al.
Cyhoeddwyd: (2021)

Chaihu-shugan-san alleviates depression-like behavior in mice exposed to chronic unpredictable stress by altering the gut microbiota and levels of the bile acids hyocholic acid and 7-ketoDCA
gan: Chong Ma, et al.
Cyhoeddwyd: (2022)

The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
gan: Ling Liu, et al.
Cyhoeddwyd: (2022)

Commentary: The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and Its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
gan: Yang Yu, et al.
Cyhoeddwyd: (2022)

Oligonucleotide therapies for nonalcoholic steatohepatitis
gan: Sixu Li, et al.
Cyhoeddwyd: (2024)

Toosendanin Induces Hepatocyte Damage by Inhibiting Autophagic Flux via TFEB-Mediated Lysosomal Dysfunction
gan: Li Luo, et al.
Cyhoeddwyd: (2022)

Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines
gan: Lijuan Xue, et al.
Cyhoeddwyd: (2023)

Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
gan: O. M. Gavrilyuk
Cyhoeddwyd: (2014)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
gan: Magdalena Mazurek, et al.
Cyhoeddwyd: (2023)

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
gan: Mehmet Yalniz, et al.
Cyhoeddwyd: (2006)

Microbiota-derived tryptophan metabolism and AMPK/mTOR pathway mediate antidepressant-like effect of Shugan Hewei Decoction
gan: Yingying Yue, et al.
Cyhoeddwyd: (2024)

Efficacy of Shugan Hewei Therapy for Chronic Atrophic Gastritis: A Systematic Review and Meta-Analysis
gan: Jing-Bin Niu, et al.
Cyhoeddwyd: (2022)

The autophagic regulation of rosiglitazone-promoted adipocyte browning
gan: Yue Li, et al.
Cyhoeddwyd: (2024)

Bardet-Biedl syndrome with nonalcoholic steatohepatitis, hypertension, and hypothyroidism
gan: Yatendra Singh, et al.
Cyhoeddwyd: (2016)

Correction: Medaka as a model for human nonalcoholic steatohepatitis
gan: Toshihiko Matsumoto, et al.
Cyhoeddwyd: (2023)

Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems
gan: Meng Zhang, et al.
Cyhoeddwyd: (2022)

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
gan: Milic S, et al.
Cyhoeddwyd: (2015)

Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse
gan: Lishan Zhou, et al.
Cyhoeddwyd: (2017)

Triglyceride peroxidation progression in lipid droplets of hepatocytes in nonalcoholic steatohepatitis
gan: Kota Saito, et al.
Cyhoeddwyd: (2024)

Ferroptosis plays a novel role in nonalcoholic steatohepatitis pathogenesis
gan: Fei Xiong, et al.
Cyhoeddwyd: (2022)

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
gan: Panshuang Qiao, et al.
Cyhoeddwyd: (2022)

Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
gan: Emmanuel A. Tsochatzis, et al.
Cyhoeddwyd: (2009)

Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats
gan: Wenhua Zhu, et al.
Cyhoeddwyd: (2017)

Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis
gan: Xiao Yu, et al.
Cyhoeddwyd: (2021)

Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction
gan: Yuwei Jiang, et al.
Cyhoeddwyd: (2022)

Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs
gan: Ruifeng Liang, et al.
Cyhoeddwyd: (2022)

Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer
gan: Fan T, et al.
Cyhoeddwyd: (2024)

Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way
gan: Wan-rong Guo, et al.
Cyhoeddwyd: (2021)